If approved, this formulation could expand access for the estimated 40% of patients who express strong needle aversion, according to survey data published in Diabetes, Obesity and Metabolism [5]
However, inactive ingredients may differ, which occasionally affects tolerability in sensitive individuals
Retatrutide works best when combined with healthy eating and regular physical activity
This product is not intended to treat, cure, diagnose, or prevent any disease
Retatrutide begins reducing appetite within the first week in most individuals, based on the GLP-1 receptor agonist class mechanism
Mounjaro vs Semaglutide Clinical research consistently shows tirzepatide-based medications like Mounjaro produce greater average weight loss than semaglutide-based medications